PIM Kinase Inhibitor, PIM447, Decreases Oncogenicity and Cancer Cell Stemness in a Human Hepatoblastoma Patient-Derived Xenograft : Journal of the American College of Surgeons

Journal Logo

Advanced Search
Surgical oncology

PIM Kinase Inhibitor, PIM447, Decreases Oncogenicity and Cancer Cell Stemness in a Human Hepatoblastoma Patient-Derived Xenograft

Wadhwani, Nikita MBBS; Marayati, Raoud MD; Quinn, Colin H. BS; Bownes, Laura V. MD; Aye, Jamie M. MD; Stewart, Jerry E. BS; Whitaker, Joseph T. BS; Yoon, Karina J. PhD; Beierle, Elizabeth A. MD, FACS

Author Information

University of Alabama at Birmingham, Birmingham, AL

Journal of the American College of Surgeons 231(4):p S277, October 2020. | DOI: 10.1016/j.jamcollsurg.2020.07.604
© 2020 by Lippincott Williams & Wilkins, Inc.

Full Text Access for Subscribers:

Log in with your American College of Surgeons credentials.
Log in with your American College of Surgeons credentials.

Not a Subscriber?

Buy
Request Permissions
Become a Society Member

You can read the full text of this article if you:

Access through Ovid